Professional Documents
Culture Documents
Polymers for
Liquid and
Semisolid
Dosage Forms
Outline
• Polymer functionality
3 ©2022
© 2022 The Lubrizol Corporation.
Overview - Carbopol® and
Pemulen™ Polymers,
Noveon® Polycarbophil
Lubrizol Pharmaceutical Polymers
Monomer:
CH2CH (COOH)
R = C10–30H21-61
MW = 72
Homopolymers Copolymers
Carbomer Copolymers Polymers of acrylic acid and a C10 – C30 alkyl acrylate crosslinked with allyl
pentaerythritol
Carbomer Interpolymers Carbomer homopolymers or copolymers that contain a block copolymer of
polyethylene glycol and a long chain alkyl acid ester
5 ©2022
© 2022 The Lubrizol Corporation.
Lubrizol Pharmaceutical Polymers
934P NF 934 NF
940 NF 941 NF
980 NF
981 NF Polymerization Solvents
5984 EP
Ethyl Acetate
Copolymer
1342 NF
Cosolvent Mixture of Ethyl
Interpolymers Acetate and Cyclohexane
ETD 2020 NF
Ultrez 10 NF
Benzene
6 ©2022
© 2022 The Lubrizol Corporation.
Choice of Polymer: Alternative Grades
• Substitute products are polymerized in either ethyl acetate or a cosolvent mixture of ethyl
acetate and cyclohexane
• Key performance properties should be determined, and full regulatory considerations
should be observed when a substitution is made in a pharmaceutical formulation
• Depending on the desired dosage requirements, other Carbopol® polymers may be
suitable alternatives
7 ©2022
© 2022 The Lubrizol Corporation.
Product Type and Regulatory Status
Pharmacopoeia Monograph Route of
Compendial Name Administration
971P NF Ethyl acetate Homopolymer APE Carbomer Homopolymer Type A Carbomers2 Carboxyvinyl Polymer ⚫ ⚫
71G NF Ethyl acetate Homopolymer APE Carbomer Homopolymer Type A Carbomers2 Carboxyvinyl Polymer ⚫ ⚫
974P NF Ethyl acetate Homopolymer APE Carbomer Homopolymer Type B Carbomers2 Carboxyvinyl Polymer ⚫ ⚫
980 NF Cosolvent Homopolymer APE Carbomer Homopolymer Type C Carbomers2 Carboxyvinyl Polymer ⚫
981 NF Cosolvent Homopolymer APE Carbomer Homopolymer Type A Carbomers2 Carboxyvinyl Polymer ⚫
1 Based on customer request, Lubrizol certifies select lots of product against the JPE Carboxyvinyl Polymer Monograph. APE = Allyl ethers of pentaerythritol
2 The Carbomers Monograph in the European Pharmacopeia stipulates that benzene is limited to 2 ppm. AS = Allyl ethers of sucrose
3 Cosolvent is a mixture of ethyl acetate and cyclohexane.
4 Carbopol® 934 NF, 934P NF, 940 NF, 941 NF and 1342 NF polymers are not recommended for new product development due to regulatory restrictions on benzene.
8 ©2022
© 2022 The Lubrizol Corporation.
Product Type and Regulatory Status (Cont’d)
Europe
Residual United States Japan
Polymers Polymer Type Crosslinker (Ph. Oral Topical
Solvent (USP/NF) (JPE)
Eur.)
Pemulen™ Polymers
Carbomer Copolymer
TR-1 NF Cosolvent Copolymer APE ⚫
Type B
Carbomer Copolymer
TR-2 NF Cosolvent Copolymer APE ⚫
Type A
Noveon® Polycarbophil
Ethyl
AA-1 USP Homopolymer DVG Polycarbophil ⚫ ⚫
Acetate
9 ©2022
© 2022 The Lubrizol Corporation.
Carbopol® Polymers – Characteristics
Particle size Flocculated powders have a Typical size range (min 85%) is 150 - 425
median diameter of 5 to 15 microns (sieve analysis)
microns.
Particle morphology Fine particles Mostly large solid chunks with clinging fines
(SEM)
10 ©2022
© 2022 The Lubrizol Corporation.
Carbopol® Polymers – Characteristics
Chemically very stable under normal storage conditions; no significant changes of the
Chemical stability
chemical parameters or detected impurities for a period of minimum 5 years
Physical stability The polymers are hygroscopic
Equilibrium moisture content
8 - 10% w/w
(25 °C and 50% RH)
Glass transition temperature ~105°C. Glass transition temperature significantly decreases in the presence of moisture
Recommended storage In airtight containers, protected from moisture and excessive temperature
11 ©2022
© 2022 The Lubrizol Corporation.
Supply Position for Pharmaceutical Grade
Products
cGMP
Manufacturing Calvert City, KY (U.S.) Antwerp (Kallo), Belgium
Locations
Solvent - Benzene - Cosolvent
Platforms - Ethyl Acetate
- Cosolvent
Products are offered through a global supply network of direct sales and distributors
12 ©2022
© 2022 The Lubrizol Corporation.
Typical Polymer
Usage Levels
Usage Level
Application
(wt. %)
13 ©2022
© 2022 The Lubrizol Corporation.
Polymer Functionality
Thickening with a Wide Range
of Flow Properties
Carbopol® Polymers - Swelling
16 ©2022
© 2022 The Lubrizol Corporation.
Carbopol® Polymers Swelling Mechanism
18 ©2022
© 2022 The Lubrizol Corporation.
Effect of Polymer Type and Concentration on
the Viscosity at pH 5.0 – Topical Products
120000
60000
40000
20000
0
0 0.5 1 1.5 2 2.5
concentration (%)
34 ©2022
© 2022 The Lubrizol Corporation.
Effect of Polymer Type and Concentration on
the Viscosity of Dispersions as Prepared
7500
3000
1500
0
0 0.5 1 1.5 2 2.5
concentration (%)
Viscosity of Carbopol® Ultrez 10 NF and ETD 2020NF polymers is low before neutralization
35 ©2022
© 2022 The Lubrizol Corporation.
Viscosity of Carbopol® Polymer Dispersions –
Hydrogen Bonding
36 ©2022
© 2022 The Lubrizol Corporation.
Suspension Stabilization
Carbopol® Polymer Suspending Ability vs.
Xanthan Gum
53 ©2022
© 2022 The Lubrizol Corporation.
Suspension Stabilization
54 ©2022
© 2022 The Lubrizol Corporation.
Emulsion Stabilization
Pemulen™ Polymers
Emulsion Stabilization – Pemulen™ Polymers
Pemulen™ polymers
• Carbomer copolymers of acrylic acid and a
long chain alkyl methacrylate crosslinked
with allyl ethers of pentaerythritol
• Have small lipophilic portion in addition to a
large hydrophilic portion
• Form O/W emulsions
70 ©2022
© 2022 The Lubrizol Corporation.
Emulsion Stabilization – Pemulen™ Polymers
Skin electrolytes
71 ©2022
© 2022 The Lubrizol Corporation.
Emulsion Stabilization - Pemulen™ Polymers
72 ©2022
© 2022 The Lubrizol Corporation.
Liquid and Semisolid Dosage Forms
Containing Carbomers or Polycarbophil
Liquid and Semisolid Products for Oral or
Peroral Administration
Trademark
Product Active Inactive Ingredients as Identified on Product Packaging
Owner
Clarithromycin Carbomer, castor oil, citric acid, hypromellose phthalate, maltodextrin,
Biaxin® Granules 125 mg/5 ml/- Abbvie Inc. potassium sorbate, povidone, silicon dioxide, sucrose, xanthan gum, titanium
250 mg/5 ml dioxide and fruit punch flavor.
Boehringer
Nevirapine Ingelheim Carbomer 934P, methylparaben, propylparaben, sorbitol, sucrose, polysorbate
VIRAMUNE® Oral Suspension
50 mg/5 ml Pharmaceuticals, 80, sodium hydroxide and purified water.
Inc.
Carbomer 974, Citronensäure 1H2O, Hypromellose, Natriumcitrat H2O-frei,
Simethicone Parke-Davis/Pfizer Natriumbenzoat, Natriumcyclamat, Macrogolstearylether, Saccharin-Natrium,
Sab simplex® Suspension
69.19 mg/1 ml Pharma Sorbinsäure, Himbeeraroma 60373 H & R, Vanille-Aroma 200817, gereinigtes
Wasser.
Sodium alginate
1 g/10 ml Calciumcarbonat, Carbomer 974P, Methyl-4-hydroxybenzoat (E 218), Propyl-4-
Gaviscon® Advance
Potassium Reckitt Benckiser hydroxybenzoat (E 216), Saccharin-Natrium, Pfefferminz-Aroma,
Pfefferminz Suspension
bicarbonate Natriumhydroxid, ger. Wasser.
0.2 g/10 ml
Hymetellose, Carbomer 974, Natriumhydroxid, Glycerol, Methyl-4-
Nystatin
Lederlind® Mundgel RIEMSER hydroxybenzoat, Propyl-4-hydroxybenzoat, Natriumcalciumedetat, Orangenaroma,
22.73 mg/g
gereinigtes Wasser.
Lidocaine
hydrochloride Aromastoffe, natürlich, naturidentisch; Dinatrium edetat; Wasser,
Kamistad®-Gel
20 mg/g Chamomile STADA gereinigtes; Carbomer; Acesulfam
STADA
flowers extract kalium; Propylenglycol; Sorbitol; Trometamol; Ethanol; Glycerol
185 mg/g
111 ©2022
© 2022 The Lubrizol Corporation.
Liquid and Semisolid Products for
Ophthalmic Administration
Trademark
Product Active Inactive Ingredients as Identified on Product Packaging
Owner
Sun 0.003% benzalkonium chloride, mannitol, citric acid, Polycarbophil,
AzaSite® (azithromycin Azithromycin
Pharmaceutical sodium citrate, poloxamer 407, edetate disodium (EDTA), sodium
1%) 1%
Industries, Inc. chloride, water for injection, and sodium hydroxide to pH 6.3.
benzalkonium chloride 0.01%, Polycarbophil, mannitol, poloxamer 407,
sodium chloride, edetate disodium dihydrate, sodium hydroxide and water for
Besivance® suspension Besifloxacin 0.6% (6ml/ml) Bausch and Lomb injection.
Besivance is an isotonic suspension with an osmolality of approximately 290
mOsm/kg
Boric acid, edetate disodium dihydrate, glycerin, Polycarbophil, propylene
Lotemax® Gel Loteprednol Etabonate 5
Bausch and Lomb glycol, sodium chloride, tyloxapol, water for injection, and sodium hydroxide
mg/g (0.5%)
to adjust to a pH of between 6 and 7, benzalkonium chloride 0.003%.
Sodium hyaluronate
Hylan® Augentropfen Pharma Stulln Carbomer 981, Glycerol, gereinigtes Wasser.
0.15 mg/ml
0.01% benzalkonium chloride, mannitol, Carbomer 974P, tyloxapol,
AZOPT® (brinzolamide Brinzolamide
Alcon edetate disodium, sodium chloride, hydrochloric acid and/ or sodium
1%) 10 mg/ml
hydroxide (to adjust pH), and purified water.
0.01% benzalkonium chloride, sorbitol ( Ph.Eur. ), Carbomer 980,
Predni-POS® 1% Prednisolone acetate
Ursapharm sodium acetate trihydrate, sodium hydroxide (to adjust pH), and purified
Augentropfen suspension 10 mg/g
water.
Mannitol, poly(styrene-divinyl benzene) sulfonic acid, Carbomer 974P,
boric acid, N-lauroylsarcosine, edetate disodium, hydrochloric acid or
Betaxon™ Ophthalmic Levobetaxolol
Alcon Labs USA tromethamine (to adjust pH) and purified water. It has a pH of 5.5 to 7.5
Suspension hydrochloride 0.5%
and an osmolality of 260 to 340 mOsm per kg, benzalkonium chloride
0.01%
Benzalkonium chloride 0.01%, Mannitol, Poly(Styrene-Divinyl Benzene)
Betoptic S® Ophthalmic sulfonic acid, Carbomer 934P, edetate disodium, hydrochloric acid or sodium
Betaxolol hydrochloride
Suspension Novartis hydroxide (to adjust pH) and purified water. BETOPTIC S® (betaxolol
0.25%
hydrochloride ophthalmic suspension) 0.25% has a pH of approximately 7.6
112 ©2022
© 2022 The Lubrizol Corporation. and an osmolality of approximately 290 mOsmol/kg
Liquid and Semisolid Products for
Ophthalmic Administration
Trademark
Product Active Inactive Ingredients as Identified on Product Packaging
Owner
Boric acid, propylene glycol, carbomer 974P, sodium chloride, guar gum,
Ilevro® Ophthalmic
Nepafenac carboxymethylcellulose sodium, edetate disodium, benzalkonium chloride
Suspension Novartis
0.3% 0.005% (preservative), sodium hydroxide and/or hydrochloric acid to adjust
pH and purified water, USP.
Fucithalmic® Fusidic Acid 0.01% w/w benzalkonium chloride, disodium edetate, mannitol, Carbomer,
Fusidic acid 1% (10mg/g). Leo Pharma
Eye drops sodium hydroxide, water for injection
Dexpanthenol Bausch and Cetrimide, Carbomer, Disodium edetat, Sodium hydroxide, Water for
Corneregel® Augengel
50 mg/g Lomb injections
RESTASIS® Ophthalmic Cyclosporine Glycerin, castor oil, polysorbate 80, Carbomer copolymer type A,
Allergan, Inc.
Emulsion 0.05% purified water and sodium hydroxide to adjust the pH.
113 ©2022
© 2022 The Lubrizol Corporation.
Liquid and Semisolid Products for
Ophthalmic Administration
Trademark
Product Active Inactive Ingredients as Identified on Product Packaging
Owner
GenTeal® Tears Severe Hypromellose 2910 (4000 Mpa.S), Carbopol 980*, GenAqua (sodium
Novartis
Hypromellose gel perborate), phosphonic acid, purified water, sodium hydroxide, and sorbitol.
114 ©2022
© 2022 The Lubrizol Corporation.
Liquid and Semisolid Products for
Mucosal Administration
Product Active Trademark Owner Inactive Ingredients as Identified on Product Packaging
115 ©2022
© 2022 The Lubrizol Corporation.
Liquid and Semisolid Products for
Skin Administration
Product Active Trademark owner Inactive ingredients as Identified on Product Packaging
Betamethasone
Betnesol®-V crinale
valerate GlaxoSmithKline Carbomer 980, 2-Propanol, Natriumhydroxid, gereinigtes Wasser
0,1%
1.22 mg/g
Estradiol
Divigel® Gel Orion Corporation Carbomer, ethanol, propylene glycol, purified water, and triethanolamine.
0.1%
116 ©2022
© 2022 The Lubrizol Corporation.
Liquid and Semisolid Products for
Skin Administration
Product Active Trademark owner Inactive ingredients as Identified on Product Packaging
Calcipotriene
Isopropyl myristate, mineral oil, medium-chain triglyceride, isopropyl alcohol, polyoxyl
50 mcg/g
lauryl ether, poloxamer (407), polyoxyl 40 hydrogenated castor oil, carbomer
WYNZORA® Cream Betamethasone MC2 Therapeutics
interpolymer type A, butylated hydroxy anisole, trolamine, dibasic sodium phosphate,
Dipropionate
monobasic sodium phosphate, DL-A-tocopherol and purified water
0.644 mg/g
carbomer copolymer type B, cetyl alcohol, citric acid monohydrate, dimethicone,
Soolantra® Topical Ivermectin edetate disodium, glycerin, isopropyl palmitate, methylparaben, oleyl alcohol,
Galderma Labs LP
Cream 1% phenoxyethanol, polyoxyl 20 cetostearyl ether, propylene glycol, propylparaben,
purified water, sodium hydroxide, sorbitan monostearate, and stearyl alcohol.
Testosterone Drug reservoir contains alcohol USP, glycerin USP, glycerol monooleate, methyl laurate,
Androderm®
2mg/24hr, Allergan, Inc. sodium hydroxide NF, to adjust pH, and purified water USP, gelled with carbomer
Transdermal Patch
4mg/24h copolymer Type B NF
Clobex® Generic,
Clobetasol Propylene glycol, water, hypromelloses, carbomer copolymer type B (allyl
Clobetasol Propionate Teligent, Inc.
Propionate 0.05% pentaerythritol crosslinked), mineral oil, sodium hydroxide, polyethylene glycol 300
topical lotion
benzyl alcohol 1%, carbomer homopolymer type B; carbomer 1342, edetate
Tazarotene
Tazorac® Cream Allergan, Inc disodium, medium chain triglycerides, mineral oil, purified water, sodium thiosulfate,
0.1%
sorbitan monooleate, and sodium hydroxide to adjust pH
Testosterone
Carbomer homopolymer type c, diisopropyl adipate, ethanol, carbomer
Vogelxo™ Transdermal 50 mg/5 g Upsher-Smith
copolymer type b, propylene glycol, polyethylene glycol, oleyl alcohol, methyl laurate,
Gel packet,12.5 mg Laboratories Inc.
tris, glycerol, purified water
/1.25 g actuation
benzyl alcohol, butylated hydroxytoluene, carbomer copolymer type B (Pemulen
Tretinoin TR-1), carbomer homopolymer type A (Carbopol 981), glycerin, methylparaben,
Altreno® Topical Lotion Dow Pharma
0.05% mineral oil, octoxynol-9, purified water, sodium hyaluronate, soluble collagen and
trolamine
Halobetasol
propionate carbomer copolymer type B, carbomer homopolymer type A, diethyl sebacate,
DUOBRII® Topical
0.01%, Bausch edetate disodium dihydrate, light mineral oil, methylparaben, propylparaben, purified
Lotion
117 ©2022
© 2022 The Lubrizol Tazarotene
Corporation. water, sodium hydroxide, sorbitan monooleate and sorbitol solution, 70%
0.045%
Conclusions
Lubrizol pharmaceutical polymers provide key benefits in liquid and semisolid dosage forms
• Versatile and efficient
• Provide rheology modification for aqueous, anhydrous and hydroalcoholic systems
at low usage levels
• Compatible with most acidic, basic and neutral drugs
• Applications across a broad pH range (4.5 – 10.0)
• No heat sensitivity compared to other thickening agents
• Multi-functional
• Highly efficient thickening, emulsion and suspension stabilization
• Can increase bioavailability of active pharmaceutical ingredients due to their
bioadhesive properties
• Safety and quality
• Demonstrated to have low irritancy and non-sensitizing properties
• Manufactured under cGMP conditions
• Consistent and reproducible properties due to their synthetic nature
• Do not support microbial growth
118 ©2022
© 2022 The Lubrizol Corporation.
Thank You
For more information, samples and/or
starting formulations with complete
processing instructions and supplier
references please contact:
120 ©2022
© 2022 The Lubrizol Corporation.